demonstrated that although high dose exenatide treatment did not exercise a significant effect on left ventricular function or area at risk, a trend was observed towards a smaller infarct size as percentage of the area at risk in patients with first acute myocardial infarction who were to be treated with primary percutaneous coronary intervention [64]
Nevertheless, treatment with semaglutide demonstrated to improve HF related symptoms in non-diabetic patients with HFpEF, and a recent meta-analysis encompassing eight trials and 60,080 patients demonstrated an overall reduction of HF-related hospital admission by 11% [115, 124]
Always choose medically approved solutions and seek professional guidance before starting any treatment
It promotes angiogenesis and possesses the ability to offer neuroprotection
Id love to hear it in the comments below
GLP-1 agonists effectively suppress appetite and promote satiety, leading to decreased calorie consumptionthe intended therapeutic effect for weight management